Clinical Trial Update: The Cook Zilver PTX Drug-eluting Stent Versus Bypass Surgery for the Treatment The Cook Zilver PTX Drug-eluting Stent Versus Bypass Surgery of Femoropopliteal TASC C&D Lesions [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing the Cook Zilver PTX drug-eluting stent to bypass surgery for femoropopliteal TASC C&D lesions in peripheral artery disease; c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Artery Disease

Drugs mentioned

• Zilver PTX Drug-Eluting Stent (paclitaxel-coated nitinol drug-eluting stent)

Snippet

Sponsor: Flanders Medical Research Program | Conditions: Peripheral Vascular Disease | Phase 4 | Status: UNKNOWN